Guru Ownership Trend
Guru Analysis for Cullinan Therapeutics, Inc. (CGEM)
Cullinan Therapeutics, Inc. (CGEM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $16.3 M.
Top institutional holders include Ken Fisher and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $8.56 M net inflow during the quarter.
Recent activity highlights Ken Fisher who dramatically increased their stake. Conversely, Cliff Asness reduced exposure by 14.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Cullinan Therapeutics, Inc. (CGEM)
Major holders include Ken Fisher ($12.29 M), Cliff Asness ($7.65 M), Renaissance Technologies (RenTech) ($4.45 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.8 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $8.56 M, with 2 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited CGEM. The total reported sell value was $3.33 M.
Yes, 0 managers opened new positions in CGEM, and 2 increased their existing holdings. The total reported buy value was $11.89 M.